Vaximm AG
Pharmaceuticals · Basel, Basel-Stadt
Vaximm AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt (UID CHE-114.477.515).
Board members & signatories
- Kuk Hwang — Mitglied des Verwaltungsrates
Registered purpose
Der Zweck der Gesellschaft ist die Forschung, Entwicklung, Herstellung, Vermarktung und der Vertrieb pharmazeutischer Produkte. Die Gesellschaft kann sich an anderen Gesellschaften beteiligen und Immaterialgüterrechte erwerben, belasten und veräussern sowie alle sonstigen kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der Gesellschaft im Zusammenhang stehen.…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Vaximm does
OFFERING
VAXIMM AG develops oral T-cell immunotherapies, focusing on precision cancer treatments. Their lead product, VXM01, is designed for use in combination with checkpoint inhibitors and has undergone clinical trials for pancreatic cancer. The company aims to deliver next-generation therapies through its robust development pipeline.
Unlock the full analysis →Similar companies
- Immunovant Sciences GmbH — Biotechnology · Basel
- Vaccentis AG — Biotechnology · Zürich
- CanVirex AG — Pharmaceuticals · Basel
- ImmunoGen Switzerland GmbH — Pharmaceuticals · Cham
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
- HilleVax GmbH — Pharmaceuticals · Zürich
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime